Drug Trial Radar · NCT05449132
Comparison of a Single RTX-GRT7039 and Placebo Intra-articular Injection for Pain Associated With Osteoarthritis of the Knee
Last checked: Nov 19, 2026Latest source record: Mar 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
466
Actual
Start
Sep 26, 2022
Primary completion
Aug 15, 2024
Study completion Aug 15, 2024
Sponsor
- Lead sponsor
- Grünenthal GmbHIndustry
- Sponsor type
- Industry
- First posted
- Jul 8, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A double-blind, randomized, placebo-controlled, parallel-group, multi-site, clinical trial to confirm the efficacy and safety of single injection of RTX-GRT7039 versus placebo in patients who have pain associated with osteoarthritis of the knee despite standard of care.
Conditions
- Osteoarthritis
Interventions
RTX-GRT7039Drug
RTX-GRT7039 intra-articular injection.
PlaceboDrug
Placebo matching RTX-GRT7039 intra-articular injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Least Squares Mean (Standard Error) [LS-mean (SE) ] Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale Score at Week 12Time frame: From Baseline up to Week 12
Locations
81 sites in 5 countries. Site status is shown where the registry gives one.
Achieve Clinical Research, LLC
Birmingham, Alabama
Arizona Arthritis and Rheumatology Associates (AARA) P.C
Glendale, Arizona
Elite Clinical Studies, LLC
Phoenix, Arizona
Noble Clinical Research
Tucson, Arizona
Tucson Orthopaedic Research Center
Tucson, Arizona
Orange County Research Institute
Anaheim, California
Core Health Care Group
Cerritos, California
Acclaim Clinical Research, Inc.
San Diego, California
Dr. Hans Richard Barthel, MD Office Of
Santa Barbara, California
Medvin Clinical Research
Thousand Oaks, California
Westlake Medical Research
Thousand Oaks, California
Allied Biomedical Research Institute
Miami, Florida
Well Pharma Medical Research, Corp.
Miami, Florida
Sensible Healthcare LLC
Ocoee, Florida
Clinical Neuroscience Solutions, Inc. dba CNS Healthcare
Orlando, Florida
Clinical Neuroscience Solutions, Inc.
Orlando, Florida
Progressive Medical Research
Port Orange, Florida
Gulfcoast Research Institute
Sarasota, Florida
Better Health Clinical Research, Inc.
Newnan, Georgia
Vista Clinical Research
Newnan, Georgia
North Georgia Clinical Research
Woodstock, Georgia
Injury Care Research
Boise, Idaho
Chicago Clinical Research Institute Inc.
Chicago, Illinois
Chicago Medical Research, LLC
Hazel Crest, Illinois
MediSphere Medical Research Center, LLC
Evansville, Indiana
Neuroscience Research Center, LLC
Overland Park, Kansas
DelRicht Research
New Orleans, Louisiana
LCMC Health Urgent Care - Lakeview
New Orleans, Louisiana
June DO,PC
Lansing, Michigan
Oakland Medical Research Center
Troy, Michigan
Sundance Clinical Research, LLC
St Louis, Missouri
Excel Clinical Research
Las Vegas, Nevada
Las Vegas Clinical Trials, LLC
North Las Vegas, Nevada
Albuquerque Clinical Trials, Inc.
Albuquerque, New Mexico
Drug Trials America
Hartsdale, New York
Upstate Clinical Research Associates
Williamsville, New York
Accellacare Research of Charlotte
Charlotte, North Carolina
Park Road Medical Clinic
Charlotte, North Carolina
Accellacare of Raleigh
Raleigh, North Carolina
Raleigh Medical Group
Raleigh, North Carolina
Showing 40 of 81 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.